23andMe Holding Co. at Credit Suisse Healthcare Conference Transcript

Nov 09, 2022 / 10:00PM GMT
Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research Analyst

All right. Welcome everyone to 31st Annual Healthcare Conference Credit Suisse. I'm Tiago Fauth, I'm a lead biotech analyst here at the bank. We're joined today by 23andMe. We have Joe and Kenneth, CFO and Chief Therapeutic Officer, respectively for our fireside chat. We will leave a few minutes towards the end if there are any questions. I'm going to start by admitting my bias. As a biotech analyst, I have to focus a little bit more on the therapeutic side, but hopefully, we'll cover a lot of ground here.

Questions and Answers:

Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research Analyst

So we can start with some broad remarks on where you guys stand today as a public entity. It's a fairly unique business model, kind of a hybrid. So where do you guys stand right now? What are some of the key business units or the way you segment your business and we'll dive right in after that.

Joseph Selsavage
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot